MET and cholangiocarcinoma: Although the MET amplification has been reported in CCA, our study highlighted the presence of MET amplification is a genomic feature of pCCA, and reported with rare amplification frequency in Caucasian iCCA43,44, suggesting that it may occur more frequently in Chinese patients.